blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2216028

EP2216028 - Immunostimulation by chemically modified single-stranded RNA [Right-click to bookmark this link]
Former [2010/32]Immunostimulation by chemically modified RNA
[2015/45]
StatusPatent revoked
Status updated on  29.05.2020
Database last updated on 20.12.2024
FormerThe patent has been granted
Status updated on  03.11.2017
FormerGrant of patent is intended
Status updated on  16.11.2016
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): CY		published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
CureVac AG
Paul-Ehrlich-Str. 15
72076 Tübingen / DE
[2015/51]
Former [2010/32]For all designated states
CureVac GmbH
Paul-Ehrlich-Strasse 15
72076 Tübingen / DE
Inventor(s)01 / Hoerr, Ingmar, Dr.
Hasenbergstrasse 99
70176 Stuttgart / DE
02 / Pascolo, Steve, Dr.
Kanzleistr. 231
8004 Zürich / CH
03 / Von der Mülbe, Florian
Alpenrosenstrasse 15a
70563 Stuttgart / DE
 [2015/09]
Former [2010/46]01 / Hoerr, Ingmar, Dr.
Charlottenstrasse 16
72070 Tübingen / DE
02 / Pascolo, Steve, Dr.
Kanzleistr. 231
8004 Zürich / CH
03 / Von der Mülbe, Florian
Alpenrosenstrasse 15a
70563 Stuttgart / DE
Former [2010/32]01 / Hoerr, Ingmar, Dr.
Charlottenstrasse 16
72070 Tübingen / DE
02 / Pascolo, Steve, Dr.
Bursagasse 12
72072 Tübingen / DE
03 / Von der Mülbe, Florian
Alpenrosenstrasse 15a
70563 Stuttgart / DE
Representative(s)Graf von Stosch, Andreas, et al
Graf von Stosch
Patentanwaltsgesellschaft mbH
Prinzregentenstraße 22
80538 München / DE
[2017/49]
Former [2010/32]Graf von Stosch, Andreas, et al
Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22
80538 München / DE
Application number, filing date10005375.003.07.2003
[2010/32]
Priority number, dateDE2002102987203.07.2002         Original published format: DE 10229872
[2010/32]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP2216028
Date:11.08.2010
Language:DE
[2010/32]
Type: A3 Search report 
No.:EP2216028
Date:29.12.2010
[2010/52]
Type: B1 Patent specification 
No.:EP2216028
Date:06.12.2017
Language:DE
[2017/49]
Search report(s)(Supplementary) European search report - dispatched on:EP30.11.2010
ClassificationIPC:A61K31/7115, A61K31/7125, A61K39/00, A61K35/66, A61P37/04
[2010/32]
CPC:
C12N15/117 (EP,US); A61K31/7115 (EP,US); A61K31/7125 (EP,US);
A61K39/0011 (EP,US); A61K39/39 (EP,US); A61K47/42 (US);
A61P35/00 (EP); A61P37/04 (EP); A61K2039/55561 (EP,US);
A61K2039/572 (US); C12N2310/17 (US); C12N2310/315 (EP,US);
C12N2320/31 (US); C12N2320/32 (US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2017/49]
Former [2010/32]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Immunstimulation durch chemisch modifizierte eingelsträngige RNA[2015/45]
English:Immunostimulation by chemically modified single-stranded RNA[2015/45]
French:Stimulation immunitaire au moyen de RNA monocaténaire modifié chimiquement[2015/45]
Former [2010/32]Immunstimulation durch chemisch modifizierte RNA
Former [2010/32]Immunostimulation by chemically modified RNA
Former [2010/32]Stimulation immunitaire au moyen de RNA modifié chimiquement
Examination procedure21.05.2010Examination requested  [2010/32]
19.04.2011Amendment by applicant (claims and/or description)
27.06.2013Despatch of a communication from the examining division (Time limit: M06)
16.12.2013Reply to a communication from the examining division
09.07.2014Despatch of a communication from the examining division (Time limit: M04)
04.11.2014Reply to a communication from the examining division
20.11.2015Communication of intention to grant the patent
17.12.2015Observations by third parties
29.12.2015Fee for grant paid
29.12.2015Fee for publishing/printing paid
29.12.2015Receipt of the translation of the claim(s)
16.03.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
11.04.2016Despatch of a communication from the examining division (Time limit: M06)
17.11.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
24.01.2017Reply to a communication from the examining division
07.02.2017Observations by third parties
04.10.2017Communication of intention to grant the patent
24.10.2017Fee for grant paid
24.10.2017Fee for publishing/printing paid
24.10.2017Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP03762622.3  / EP1521585
EP06007325.1  / EP1685844
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030762622) is  12.04.2005
Opposition(s)Opponent(s)01  04.09.2018    ADMISSIBLE
Schnappauf, Georg
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
 02  05.09.2018    ADMISSIBLE
Strawman Limited
Orchard Lea
Horns Lane
Combe, Witney
Oxfordshire OX29 8NH / GB
Opponent's representative
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
 03  06.09.2018    ADMISSIBLE
eTheRNA Immunotherapies NV
Galileilaan 19
2845 Niel / BE
Opponent's representative
LC Patents
Kempische Steenweg 542A
3500 Hasselt / BE
 [2018/41]
18.09.2018Invitation to proprietor to file observations on the notice of opposition
28.01.2019Reply of patent proprietor to notice(s) of opposition
05.12.2019Date of oral proceedings
05.12.2019Legal effect of revocation of patent [2020/27]
16.01.2020Despatch of minutes of oral proceedings
16.01.2020Despatch of communication that the patent will be revoked
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
24.01.2017Request for further processing filed
24.01.2017Full payment received (date of receipt of payment)
Request granted
15.02.2017Decision despatched
Fees paidRenewal fee
21.05.2010Renewal fee patent year 03
21.05.2010Renewal fee patent year 04
21.05.2010Renewal fee patent year 05
21.05.2010Renewal fee patent year 06
21.05.2010Renewal fee patent year 07
21.05.2010Renewal fee patent year 08
16.05.2011Renewal fee patent year 09
14.05.2012Renewal fee patent year 10
21.05.2013Renewal fee patent year 11
10.06.2014Renewal fee patent year 12
22.06.2015Renewal fee patent year 13
06.06.2016Renewal fee patent year 14
22.05.2017Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.07.2003
CY06.12.2017
CZ06.12.2017
DK06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
IT06.12.2017
MC06.12.2017
NL06.12.2017
PT06.12.2017
RO06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
TR06.12.2017
BG06.03.2018
GR07.03.2018
AT03.07.2018
IE03.07.2018
LU03.07.2018
BE31.07.2018
[2020/31]
Former [2020/27]HU03.07.2003
CZ06.12.2017
DK06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
IT06.12.2017
MC06.12.2017
NL06.12.2017
PT06.12.2017
RO06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
TR06.12.2017
BG06.03.2018
GR07.03.2018
AT03.07.2018
IE03.07.2018
LU03.07.2018
BE31.07.2018
Former [2020/16]CZ06.12.2017
DK06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
IT06.12.2017
MC06.12.2017
NL06.12.2017
RO06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
TR06.12.2017
BG06.03.2018
GR07.03.2018
AT03.07.2018
IE03.07.2018
LU03.07.2018
BE31.07.2018
Former [2020/03]CZ06.12.2017
DK06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
IT06.12.2017
MC06.12.2017
NL06.12.2017
RO06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
AT03.07.2018
IE03.07.2018
LU03.07.2018
BE31.07.2018
Former [2019/24]CZ06.12.2017
DK06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
IT06.12.2017
MC06.12.2017
NL06.12.2017
RO06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
IE03.07.2018
LU03.07.2018
BE31.07.2018
Former [2019/19]CZ06.12.2017
DK06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
IT06.12.2017
MC06.12.2017
NL06.12.2017
RO06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
IE03.07.2018
LU03.07.2018
Former [2019/17]CZ06.12.2017
DK06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
IT06.12.2017
MC06.12.2017
NL06.12.2017
RO06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
LU03.07.2018
Former [2019/15]CZ06.12.2017
DK06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
IT06.12.2017
MC06.12.2017
NL06.12.2017
RO06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
Former [2018/52]CZ06.12.2017
DK06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
IT06.12.2017
NL06.12.2017
RO06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
Former [2018/51]CZ06.12.2017
DK06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
IT06.12.2017
NL06.12.2017
RO06.12.2017
SE06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
Former [2018/41]CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
IT06.12.2017
NL06.12.2017
RO06.12.2017
SE06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
Former [2018/37]CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
NL06.12.2017
SE06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
Former [2018/34]ES06.12.2017
FI06.12.2017
NL06.12.2017
SE06.12.2017
BG06.03.2018
GR07.03.2018
Former [2018/24]ES06.12.2017
FI06.12.2017
SE06.12.2017
BG06.03.2018
GR07.03.2018
Former [2018/23]ES06.12.2017
FI06.12.2017
SE06.12.2017
GR07.03.2018
Former [2018/22]ES06.12.2017
FI06.12.2017
Documents cited:Search[Y]EP0839912  (INSTITUUT VOOR DIERHOUDERIJ EN [NL]);
 [Y]US5965720  (GRYAZNOV SERGEI M [US], et al);
 [Y]US6322967  (PARKIN NEIL T [US]);
 [Y]WO0193902  (BIOSYNEXUS INC [US]);
 [Y]WO0200694  (AMERICAN CYANAMID CO [US], et al);
ExaminationWO03028656
 EP1685844
by applicantUS4373071
 US4401796
 US4415732
 US4458066
 US4500707
 US4668777
 US4973679
 US5047524
 US5132418
 US5153319
 US5262530
 US5663153
 US5700642
 EP1083232
 US6239116
 US6406705
otherWO0193902
 WO03086280
 WO2010037539
OppositionUS5723335
 WO9914346
 WO0102007
 WO0104313
 EP1083232
 US2002064515
 WO02061113
 WO02098443
 WO03051401
 WO9855495
 US6406705
 WO03086280
 WO2004004743
 EP2216028
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.